FAM
ARIA

Fred Alger Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Fred Alger Management’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-237,733
Closed -$2.96M – 571
2016
Q4 		$2.96M Buy
237,733
+27,187
+13% +$327K 0.02% 231
2016
Q3 		$2.88M Buy
210,546
+59,246
+39% +$595K 0.01% 237
2016
Q2 		$1.12M Buy
151,300
+89,300
+144% +$670K 0.01% 320
2016
Q1 		$396K Buy
+62,000
New +$347K ﹤0.01% 430
2015
Q4 		– Sell
-82,650
Closed -$483K – 614
2015
Q3 		$483K Buy
+82,650
New +$637K ﹤0.01% 438
2015
Q2 		– Sell
-181,250
Closed -$1.49M – 564
2015
Q1 		$1.49M Buy
181,250
+80,600
+80% +$596K 0.01% 467
2014
Q4 		$691K Buy
+100,650
New +$630K ﹤0.01% 443
2013
Q4 		– Sell
-157,270
Closed -$2.89M – 616
2013
Q3 		$2.89M Buy
+157,270
New +$3.05M 0.02% 369

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Fred Alger Management's ARIA Position: Q1 2017 in Review

Fred Alger Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 237,733 shares — an estimated $2.96M sold.

Fred Alger Management first reported a position in ARIA in Q3 2013 and held it in 8 quarters. The position peaked at $2.96M in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Fred Alger Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Fred Alger Management sold 237,733 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $2.96M.
  • Fred Alger Management first reported a position in Ariad Pharmaceuticals Inc in Q3 2013 and held it in 8 quarters.
  • Fred Alger Management's Ariad Pharmaceuticals Inc position peaked at $2.96M in Q4 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Fred Alger Management's 13F filing for Q1 2017, filed 15 May 2017.